TrialJournal of acquired immune deficiency syndromes (1999)2017

Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1-Infected Adults.

Joel E Gallant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.